Regulated Information
Financial Reports
06
May
2022
Celyad Oncology Announces First Quarter 2022 Financial Results and Recent Business Highlights
SEC Filings
Filter
| Filing Date | Form | Description | Filing Group | Downloads |
|---|---|---|---|---|
| September 22, 2022 | 6-K | Cellistic and Celyad Oncology Announce GMP Cell Therapy Manufacturing Operations Transaction | ||
| August 5, 2022 | 6-K | Celyad Oncology Reports First Half 2022 Financial Results and Recent Business Highlights | ||
| August 1, 2022 | 6-K | Celyad Oncology Announces FDA Lifts Clinical Hold of CYAD-101-002 Phase 1b Trial | ||
| June 24, 2022 | 6-K | Celyad Oncology Announces Leadership Updates | ||
| May 7, 2022 | 6-K | Celyad Oncology Announces First Quarter 2022 Financial Results and Recent Business Highlights | ||
| March 25, 2022 | 6-K | Celyad Oncology Reports Full Year 2021 Financial Results and Recent Business Highlights |
Regulated Information
Filter
Interim Financial Report – First Half 2022
RAPPORT FINANCIER INTERMEDIAIRE
Summary Note – Listing Prospectus
